Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide (Zepbound) comes as a once-weekly injection only
About Daiichi Sankyo Group Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose "to contribute to the enrichment of quality of life around the world." In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs
Intervention duration influences the cumulative process from molecular adaptations to tissue-level pathological improvements
.jpg)
(2005) Incretin mimetics as emerging treatments for type 2 diabetes
US$ 24.52
US$ 24.53
US$ 24.14
US$ 24.86
US$ 24.36
US$ 26.34
US$ 20.47
US$ 23.99
US$ 21.05
